Expo

CPHI Japan
CPHI japan

CPHI Japan

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to CPHI Japan 2024

read more
2400 1800 Anemocyte.com
Cell & Gene
cell gene meeting

Cell & Gene

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Cell & Gene Meeting 2024 in Rome

read more
2400 1800 Anemocyte.com
Advanced Therapies
advanced therapies

Advanced Therapies

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Advanced Therapies 2024 in London

read more
2400 1800 Anemocyte.com
RNA Leaders Europe
rna leaders europe congress

RNA Leaders Europe

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to RNA Leaders Europe Congress 2024 in Basel, Switzerland.

read more
2400 1800 Anemocyte.com
mRNA-Based Therapeutics Summit
mrna therapeutics Summit

mRNA-Based Therapeutics Summit

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to mRNA Based Therapeutics Summint 2024 in Berlin.

read more
2400 1800 Anemocyte.com
ESGCT
european society gene therapy logo

ESGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to European Society of Gene & Cell Therapy 2023 in Brussels

read more
1200 900 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961